CareDx, Inc (CDNA) vs Xenon Pharmaceuticals Inc. (XENE)
A side-by-side comparison of CareDx, Inc and Xenon Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDNA
CareDx, Inc
$63.79HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
XENE
Xenon Pharmaceuticals Inc.
$36.54HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT
Total return — CDNA vs XENE
growth of $100 · dividends reinvested · last 10yCDNA +1824.2% (+34.4%/yr)XENE +369.0% (+16.7%/yr)CDNA compounded faster over this window
CDNA XENE
CDNA vs XENE: by the numbers
- •XENE is the larger company ($3.53B vs $3.30B market cap).
- •CDNA is profitable (24.23% net margin) while XENE runs a net loss (-4612.13%).
Metrics side by side
Valuation
| Metric | CDNA | XENE |
|---|---|---|
| P/E ratio | 30.80 | N/A |
| Forward P/E | 53.26 | N/A |
| P/S ratio | 7.20 | N/A |
| P/B ratio | 7.75 | 2.84 |
| EV / EBITDA | 189.34 | N/A |
| FCF yield | 2.58% | N/A |
Profitability
| Metric | CDNA | XENE |
|---|---|---|
| Gross margin | 70.58% | 66.09% |
| Operating margin | -0.92% | -4974.27% |
| Net margin | 24.23% | -4612.13% |
| ROE | 26.08% | -32.94% |
| ROIC | -0.93% | -35.27% |
Growth (annualized)
| Metric | CDNA | XENE |
|---|---|---|
| Revenue CAGR (5Y) | 12.56% | N/A |
| Total return CAGR (5Y) | 1.33% | 4.61% |
Frequently asked
- Is CDNA or XENE more profitable?
- CDNA runs the higher net margin — CDNA at 24.23% versus XENE at -4612.13%.
- How have CDNA and XENE total returns compared?
- Over the past 10 years, CDNA delivered 34.41% and XENE delivered 17.07% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CareDx P/E ratioCareDx ROEXenon Pharmaceuticals ROECareDx operating marginXenon Pharmaceuticals operating marginCareDx revenue growthXenon Pharmaceuticals revenue growthCareDx free cash flowXenon Pharmaceuticals free cash flow
CareDx & Xenon Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.